Company Name, Ticker, Customers, else..

• Revenue Y/Y

• Op. Income Y/Y

• Cop. Income Y/Y

• Net Income Y/Y

• Eps Cop. Y/Y

• Eps Net Y/Y

• Free Cash Flow Y/Y

• Cash Flow Y/Y

• Net Inc. Y/Y Annual

Valuation Comparisons

Management Effectiveness

Financial Strength

Dividend Comparisons

Syros Pharmaceuticals Inc (SYRS)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

SYRS's Net Income Growth by Quarter and Year

Syros Pharmaceuticals Inc 's Net Income results by quarter and year

Select the Comparisons :

None ▼

Select the Ratio:

Net Income Growth Y/Y▼

None ▼

Net Income Growth Y/Y▼

SYRS Net Income (in millions $)		FY 2022	FY 2021	FY 2020	FY 2019
IV Quarter	December	-4.77	-23.81	-30.13	-19.73
III Quarter	September	-30.25	-26.03	-19.49	-19.79
II Quarter	June	-34.48	-22.49	-17.20	-19.46
I Quarter	March	-25.15	-14.23	-17.23	-16.46
FY		-94.65	-86.56	-84.05	-75.44

SYRS Net Income forth quarter 2022 Y/Y Growth Comment

Syros Pharmaceuticals Inc in the forth quarter 2022 recorded net loss of $ -4.77 millions.

According to the results reported in the forth quarter 2022, Syros Pharmaceuticals Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Syros Pharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. in the forth quarter 2022.

SYRS Net Income ( Y/Y Growth %)		2022	2021	2020	2019
IV Quarter	December	-	-	-	-
III Quarter	September	-	-	-	-
II Quarter	June	-	-	-	-
I Quarter	March	-	-	-	-
FY		-	-	-	-

Financial Statements
Syros Pharmaceuticals Inc 's forth quarter 2022 Net Income	$ -4.77 millions	SYRS's Income Statement
Syros Pharmaceuticals Inc 's forth quarter 2021 Net Income	$ -23.81 millions	Quarterly SYRS's Income Statement
New: More SYRS's historic Net Income Growth >>

SYRS Net Income (Quarter on Quarter Growth %)		2022	2021	2020	2019
IV Quarter	December	-	-	-	-
III Quarter	September	-	-	-	-
II Quarter	June	-	-	-	-
I Quarter	March	-	-	-	-
FY (Year on Year)		-	-	-	-

Compare SYRS Profitability >> Back to SYRS Growth rate Comparisons >>

Net Income forth quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income forth quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Syros Pharmaceuticals Inc 's Q/Q Net Income Growth

Net Income Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

SYRS's IV. Quarter Q/Q Net Income Comment

Although Syros Pharmaceuticals Inc in the IV. Quarter 2022 revealed net loss of $ -4.77 millions, it should be mentioned, that current results show improvement compare to the -30.25 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Net Income growth. While Syros Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .

Net Income Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income Q/Q Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

SYRS's IV. Quarter Q/Q Net Income Comment

Even if Syros Pharmaceuticals Inc in the IV. Quarter 2022 showed net loss of $ -4.77 millions, some analyst mentioned, that current results point to slight up side relative to the -30.25 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Net Income growth. While Syros Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .

Syros Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year

Net Income TTM Growth	12 Months Ending (Dec 31 2022)	12 Months Ending (Sep 30 2022)	12 Months Ending (Jun 30 2022)	12 Months Ending (Mar 31 2022)	12 Months Ending (Dec 31 2021)
Cumulative Net Income 12 Months Ending	$ -94.65	$ -113.69	$ -109.47	$ -97.48	$ -86.56
Y / Y Net Income Growth (TTM)	-	-	-	-	-
Year on Year Net Income Growth Overall Ranking	#	#	#	#	#
Seqeuential Net Income Change (TTM)	-	-	-	-	-
Seq. Net Income Growth (TTM) Overall Ranking	#	#	#	#	#

New: More SYRS's historic Net Income Growth >>

Cumulative Net Income growth Comment

Syros Pharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -95 millions in the Dec 31 2022 period.

Syros Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income TTM Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income TTM Q/Q Growth Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Cumulative Net Income growth Comment

Syros Pharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -95 millions in the Dec 31 2022 period.

Syros Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income TTM Y/Y Growth Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall	#

Net Income TTM Y/Y Growth Statistics
High	Average	Low
0 %	0 %	0 %

Net Income TTM Q/Q Growth Company Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SYRS's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SYRS's Competitors
Net Income Growth for Syros Pharmaceuticals Inc 's Suppliers
Net Income Growth for SYRS's Customers

You may also want to know
SYRS's Annual Growth Rates	SYRS's Profitability Ratios	SYRS's Asset Turnover Ratio	SYRS's Dividend Growth
SYRS's Roe	SYRS's Valuation Ratios	SYRS's Financial Strength Ratios	SYRS's Dividend Payout Ratio
SYRS's Roa	SYRS's Inventory Turnover Ratio	SYRS's Growth Rates	SYRS's Dividend Comparisons

Companies with similar Net Income no change for the quarter ending Dec 31 2022 within Healthcare Sector	Y/Y Change %	Net Income for the quarter ending Dec 31 2022
Halozyme Therapeutics Inc	-1.29%	$ -1.293 millions
Inmode Ltd	-2.15%	$ -2.153 millions
Vanda Pharmaceuticals Inc	-3.07%	$ -3.066 millions
Pro Dex Inc	-4.97%	$ -4.973 millions
Iradimed Corporation	-5.63%	$ -5.627 millions
Amedisys Inc	-7.24%	$ -7.245 millions
Biontech Se	-8.34%	$ -8.337 millions
Lemaitre Vascular Inc	-8.87%	$ -8.874 millions
Acadia Healthcare Company Inc	-11.71%	$ -11.709 millions
Intuitive Surgical Inc	-12.02%	$ -12.020 millions
Eton Pharmaceuticals Inc	-12.22%	$ -12.223 millions
Steris Plc	-13.82%	$ -13.815 millions
Envista Holdings Corporation	-14.34%	$ -14.336 millions
Bristol myers Squibb Company	-14.63%	$ -14.629 millions
Amgen Inc	-14.90%	$ -14.903 millions
Stryker Corp	-14.95%	$ -14.955 millions
Exagen Inc	-15.49%	$ -15.489 millions
Uniqure N v	-17.07%	$ -17.069 millions
Qiagen N v	-17.44%	$ -17.438 millions
Natural Health Trends Corp	-18.97%	$ -18.966 millions
Merck and Co Inc	-19.90%	$ -19.899 millions
Chemed Corporation	-21.27%	$ -21.266 millions
Rapid Micro Biosystems Inc	-22.31%	$ -22.312 millions
Select Medical Holdings Corp	-23.04%	$ -23.037 millions
Baxter International Inc	-23.55%	$ -23.554 millions
Becton Dickinson And Company	-24.93%	$ -24.926 millions
Fresenius Medical Care Ag and Co Kgaa	-26.64%	$ -26.636 millions
Syneos Health Inc	-26.90%	$ -26.897 millions
Universal Health Services Inc	-27.17%	$ -27.165 millions
Hca Healthcare Inc	-28.45%	$ -28.448 millions


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar SONM's Profile Stock Price SONM's Financials Business Description Fundamentals Charts & Quotes SONM's News Suppliers SONM's Competitors Customers & Markets Economic Indicators SONM's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071